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Abstract
ABSTRACT: Myositis ossificans (MO) in the head and neck is a rare heterotropic bone formation
within a muscle. Besides fibrodysplasia ossificans progressiva, traumatic and neurogenic forms are
described in the literature. We are presenting the case of a 35-year-old female patient with a very rare
form of MO of both masseter muscles after 4 weeks of intensive care because of complications (critical
illness neuropathy) after chemoradiotherapy. Therefore, special attention should be paid to surgical
trauma. As in the present case, radiotherapy, long-time intubation with immobilization and critical
myopathy and neuropathy can cause MO with severe problems, such as trismus and reduced mouth
hygiene, which can lead to reduced quality of life.
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Abstract
Myositis ossificans in the head and neck is a rare heterotropic bone formation within
a muscle. Besides fibrodysplasia ossificans progressiva, traumatic and neurogenic
forms are described in the literature.
We are presenting the case of a 35-year-old female patient with a very rare form of
MO of both masseter muscles after 4 weeks of intensive care because of
complications (critical illness neuropathy) after chemotherapy.
Therefore, special attention should be paid to surgical trauma. As in the present
case, radiotherapy, long-time intubation with immobilization and critical myopathy and
neuropathy can cause MO with severe problems, such as trismus and reduced
mouth hygiene, which can lead to reduced quality of life.
Introduction
Myositis ossificans is a heterotropic bone formation within a muscle. The incidence in
head and neck is rare; it is mainly found (80%) in the extremities [1]. Concerning the
head and neck, involvement of the temporal muscle [2], the masseter muscle [3], the
buccinators muscle [1], the platysma muscle [4] and the sternocleidomastoid muscle
[5] is described. Myositis ossificans can be divided into subtypes (Table 1). The
fibrodysplasia ossificans progressiva, a rare autosomal-dominant disorder, has a
prevalence of 1 in 2 million people and an onset in early childhood [6].
Traumatic myositis ossificans, also called Myositis ossificans circumscripta, is the
most common form, resulting in an ossification of muscle after trauma or
inflammation.
Case
A 35-year-old female patient was referred because of the progressive decrease in the
range of motion of her mandible for 2 years. Three years before, she underwent
chemoradiotherapy because of an Epstein-Barr virus associated nasopharyngeal
carcinoma (cT4cN2bMo). After the 2cd chemotherapy with platinol/5-FU, she
developed an aplasia with 0.03 *103/µl leucocytes (initially 4.5). In the course of the
disease she developed several complications, such as pseudomonas sepsis, renal
insufficiency, hepatopathology and repeating asystole caused by cardio toxic effect of
5-Fluorouracil. Finally she revealed a critical illness neuropathy while being intubated
for 4 weeks in an intensive care unit.
Clinical examination revealed a strong tenderness of both masseter muscles, anterior
to the superior border of the ramus and reaching from the zygomatic arch to the body
of the mandible without pain on palpation. Additionally, no pain was elicited on
palpation of the temporomandibular joint on both sides. The maximum incisal
opening was 1 cm with limited lateral excursions (Fig. 1). Limited intraoral
examination revealed reduced mouth hygiene, several teeth with severe dental
caries, and a bony hard mass in both buccal sulci.
The panoramic radiograph revealed an amorphous calcification within the soft tissue
on both sides and multiple dental caries (Fig. 2a and Fig. 2b).
Axial and coronal computed tomography scans were obtained of the facial skeleton,
and bilateral diffuse calcification of the masseter muscles without involvement of
temporal and pterygoid muscles or temporomandibular joint on both sides was seen
(Fig. 3a and Fig. 3b). A well-circumscribed calcified mass with density similar to bone
was clearly separated from the adjacent mandibular ramus. Laboratory data were all
within normal limits.
The history of long immobilisation, in combination with critical illness neuromyopathy,
radiotherapy, clinical examination, and radiographic findings on both masseter
muscles, was strongly suggestive of the diagnosis of myositis ossificans. Extraction
of caries teeth and an active mouth opening were performed using anaesthetic
intubation (fiberoptic nasal intubation). As a second step, 8 months later, 3 implants
were inserted in the upper jaw and 4 implants in the lower jaw (Fig. 2b). Concerning
trismus, physical therapy and TheraBite® training have been initiated, but the mouth
opening is still unchanged (1 cm). The patient is still seen by us once a year for
control and regularly by a dental hygienist.
Discussion
The pathophysiology is still unclear. Bone morphogenetic protein expression is
discussed because of muscle trauma resulting in stem cells differentiating into
osteoblasts and finally leading to ossification. Therefore, one treatment strategy can
be bone morphogenic protein type I receptor inhibition in order to reduce this
heterotropic ossification [7]. Aho et al. [8] were able to show in a rabbit model that
microinjury and subsequent muscle necrosis can cause invasion of macrophages
and release osteogenic growth factors.
Concerning the aetiology of myositis ossificans traumatica of the masticatory
muscles, several causes have been described: tooth extraction associated with
involvement of the buccinator muscle [1], local anaesthesia with involvement of the
pterygoid muscle, and direct force with myositis ossificans traumatica of the
masseter. In table 2 all cases with masseter involvement between 1954 and 2008 is
presented.
Different facts are important for the development of myositis ossificans on both
masseter muscles in the present case. On the one hand, the neurogenic component
plays an important role because of long time intubation and immobilization with
incomplete pareses C3 and critical myopathy/neuropathy (CIPNM) in an intensive
care unit. On the other hand, the traumatic/inflammatory component plays an
important role with sepsis. CIPNM occurs in 25-63% of patients who have been on an
artificial respirator for at least 1 week [9]. In patients with sepsis, the incidence
increases, and male patients develop this condition about twice as often as females
[9].
Microcirculatory damage can reduce delivery of oxygen and glucose and therefore
affect the nervous system, leading to CIPNM with selective myosin loss in muscles
fibres and myonecrosis by inflammatory factors [10]. Factors that are associated with
the development of CIPNM can be physical, surgical trauma, or chemicals in
combination with sepsis and the application of neuromuscular blocking agents and
steroids. These neuromuscular blocking agents are metabolized by the liver and
kidney [11]. If these organs fail, as in the present case, the effect of these blocking
agents will be prolonged. Flaccid weakness of neck flexors and facial muscles are
described as a feature in CIPNM [11], but cranial nerve involvement seems to be rare
[9]. But no case in combination with myositis ossificans has been described in the
literature.
Another important factor could be the tube change with forced mouth opening without
regular oral physiotherapy while being intubated without leading to a bleeding in an
already fibrotic muscle after previous radiotherapy.
Bilateral involvement of the masseter muscles is extremely rare. The first case in the
literature was presented in 1954 by Beck [12].
Different treatment strategies have been discussed in the literature for myositis
ossificans traumatica: surgical treatment (excision), physiotherapy (including
TheraBite), medical therapy (non-steroidal anti-inflammatory drugs, bisphosphonates
and magnesium), and low-dose radiation therapy [13]. Low-dose radiation therapy
and non-steroidal anti-inflammatory drugs are used in order to inhibit mesenchymal
differentiation into osteoblasts. The use of bisphosphonates in order to prevent
myositis ossificans is described in orthopaedics [14].
An excision was not an option in the present case because of the complete
involvement of both masseter muscles. Medical therapy was not offered because the
patient was presented with a 2-year history of complaints, so the early phase of
calcification was already over. The use of etidronate can also lead to osteomalzia
with bisphosphonate-associated necrosis of the jaws, so the patient did not receive
this agent.
Summary
Myositis ossificans is a rare complication that can be caused by muscle trauma.
Therefore, special attention should be paid to surgical trauma. As in the present
case, radiotherapy, long-time intubation with immobilization and critical myopathy and
neuropathy can cause myositis ossificans with severe problems, such as trismus and
reduced mouth hygiene, which can lead to reduced quality of life. Hence, in cases
involving trismus, after a long period of immobilisation, early intensive physiotherapy
is indicated.
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Table 1: Clinical subdivision of MO
Fibrodysplasia ossficans progressiva Symmetric congenital malformations of
great toes, ossification of upper
extremities and back
Traumatic MO Circumscript new bone growth within the
muscle after injury
Neurogenic MO Occurs below spinal-cord injury
Table 2: overview of masseter involvement between 1954 and 2008
Author Year Masseter Side Aetiology
Yano [15] 2005 bilateral Struck on both cheeks
Aoki [16] 2002 one Struck on the cheek
Geist [17] 1998 one Mandible fracture
Myoken [18] 1998 one Trauma
Steiner [3] 1997 one
one
Mandible fracture
Shotgun
Lello [19] 1986 one Struck on the cheek
Arima [20] 1984 one Struck on the cheek
Christmas [21] 1982 one Fall from horse
Beck [12] 1954 bilateral Lower jaw fracture
Legend
Figure 1: Patient with max. mouth opening
Figure 2a. Panoramic radiograph with radiopaque mass (arrow)
Figure 2b. After insertion of implants
Figure 3a and b. Calcified mass (arrow) in the masseter muscle on both sides
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